Alprazolam in the treatment of generaliz
โ
G. Chouinard; L. Annable; R. Fontaine; L. Solyom
๐
Article
๐
1982
๐
Springer
๐
English
โ 472 KB
In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage